![]() These receptors are involved in a person's reward-motivated behaviors. Other drugs in this class are Saphris (asenapine maleate), Clozaril (clozapine), Seroquel (quetiapine fumarate), and Risperdal (risperidone).Ībilify works by blocking receptors in the brain's dopamine pathways. It's one of the “second generation” atypical antipsychotic medications, commonly known as SGAs. It's not approved to treat dementia, and can increase the risk of death in patients suffering from dementia.Ībilify (aripiprazole) initially received FDA approval in 2002. ![]() It's supposed to decrease hallucinations, disorganized thinking, mood swings, depressive thoughts, and tics. In 2019, a confidential settlement was reached involving all Abilify compulstive injury claims filed in the federal court MDL.Ībilify is an anti-psychotic medication used to treat schizophrenia, bipolar disorder, Tourette’s syndrome, autism, and depression. In May 2018, the first three cases scheduled for trial settled for an unknown amount. ![]() In 2016, the United States Judicial Panel on Multidistrict Litigation ruled that all federal lawsuits involving Abilify and the connection to compulsive behavior are to be handled by a federal judge in the Northern District of Florida. The company also paid $30 million to the state of California for illegally paying doctors to prescribe its medication. In 2016, Bristol-Myers Squibb paid $19.5 million to several state governments to settle claims that the company minimized the risks of Abilify, misrepresented data from clinical trials, and illegally promoted the drug for "off-label" purposes. government $4 million to settle claims that the company marketed Abilify to child psychiatrists and nursing homes for unapproved “off-label” purposes. In 2008, Otsuka Pharmaceutical paid the U.S. government to settle claims that the company marketed Abilify to elder patients and children for unapproved “off-label” purposes. In 2005, Bristol-Myers Squibb paid a $515 million penalty to the U.S. However, you should not stop taking Abilify without first speaking with your treating doctor. Taking Abilify during pregnancy may cause harm to the newborn, such as withdrawal symptoms, breathing difficulties, and feeding problems. Family members should carefully monitor children who take Abilify. Pre-teens sometimes experience suicidal thoughts when taking this type of medication. Diabetics should check their blood sugar levels on a regular basis. Some patients experience high blood sugar (hyperglycemia) when taking Abilify. The most common side effects caused by Abilify are anxiety blurred vision constipation dizziness drooling drowsiness headache lightheadedness nausea restlessness trouble sleeping and weight gain. It appears that Abilify affects a patient's dopamine level, which then influences the individual's feelings of pleasure. Patients can't stop performing these actions even though they desperately want to stop, and the actions are causing harm. Please note that in some matters, we may co-counsel or refer the case to another lawyer or law firm.Abilify can cause addictive behavior. Please call our Defect Drug Lawyers or contact us here for a free consultation. If you or a loved one suffered compulsive behaviors after taking Abilify, you may be entitled to compensation. The FDA ordered Abilify to add warning labels as more deaths were seen with elderly patients with dementia. Food and Drug Administration (FDA) issued a public health advisory about certain drugs (Abilify, Seroquel, Risperdal, and others) used to treat behavioral problems in elderly patients with dementia. Some patients of the drug experienced extreme debt, home loss, permanent disability, and even death. Other side effects included anxiety, fatigue, dizziness, headaches, insomnia, high blood sugar, and suicidal tenancies. These behaviors included compulsive gambling, compulsive spending, compulsive eating, hypersexuality, and stealing or shoplifting. The major claim against the manufacturers is that they knew of the alleged tendency for causing compulsive behaviors. It is also marketed to treat irritability associated with autism.Ĭlaims against Abilify are that the drug was negligently manufactured and designed, and the drug maker failed to provide adequate instructions and warnings of its risk to the public. and Bristol-Myers Squibb Company, is an Antipsychotic drug marketed to treat schizophrenia, bipolar disorder, depression, and Tourette syndrome. Abilify Gambling Addiction Litigation Attorneys West Palm Beach and Palm Beach CountyĪbilify (Abilify Maintena and Aristada), manufactured by Otsuka Pharmaceutical Co.
0 Comments
Leave a Reply. |